A phase 3, multicenter, randomized, allopurinol-controlled study assessing the safety and efficacy of oral febuxostat in Chinese gout patients with hyperuricemiaShaoyong Xu, Qiuhe Ji, Jie Ming et al.|International Journal of Rheumatic Diseases|2015Cited by 55